Conservative management of well-differentiated thyroid cancer

Canadian Journal of Surgery

Volumn 53, Issue 2, 2010, Pages 109-118

  Hassanain, Mazen ^a   Wexler, Marvin ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950839529     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Jatzko GR, Lisborg PH, Muller MG, et al. Recurrent nerve palsy after thyroid operations - principal nerve identification and a literature review. Surgery 1994;115:139-44.
2. Moulton-Barrett R, Crumley R, Jalilie S, et al. Complications of thyroid surgery. Int Surg 1997;82:63-6. (Pubitemid 27243670)
3. Filho JG, Kowalski LP. Postoperative complications of thyroidectomy for differentiated thyroid carcinoma. Am J Otolaryngol 2004;25:225-30. (Pubitemid 38953658)
4. Mazzaferri EL. An overview of the management of papillary and follicular thyroid carcinoma. Thyroid 1999;9:421-7. (Pubitemid 29244917)
5. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 1997;4:328-33. (Pubitemid 127725237)
6. Shaha AR. Thyroid cancer: extent of thyroidectomy. Cancer Control 2000;7:240-5.
7. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol 2005;12:81-9.
8. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53. (Pubitemid 19011971)
9. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-7, discussion 7-8.
10. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-24. (Pubitemid 20261828)
11. Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 1998;83:1012-21. (Pubitemid 28401936)
12. Greene FL, Page DL, Fleming ID, et al., editors; American Joint Committee on Cancer. AJCC cancer staging handbook: from the AJCC cancer staging manual. 6th ed. New York (NY): Springer; 2002.
13. Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 2006;107:1255-64. (Pubitemid 44452774)
14. Pellegriti G, Giuffrida D, Scollo C, et al. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis. Cancer 2002;95:2076-85. (Pubitemid 35253368)
15. Mills SC, Haq M, Smellie WJ, Harmer C. Hürthle cell carcinoma of the thyroid: retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol 2009;35:230-4.
16. Stojadinovic A, Hoos A, Ghossein RA, et al. Hurthle cell carcinoma: a 60-year experience. Ann Surg Oncol 2002;9:197-203. (Pubitemid 34259708)
17. Furlan JC, Bedard YC, Rosen IB. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. J Am Coll Surg 2004;198:341-8.
18. D'Avanzo A, Treseler P, Ituarte PH, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer 2004;100:1123-9. (Pubitemid 38325938)
19. Lin JD, Chao TC, Chen ST, et al. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging. Surg Oncol 2007;16:107-13.
20. Lo CY, Chan WF, Lam KY, et al. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 2005;242:708-15.
21. Wein RO, Weber RS. Contemporary management of differentiated thyroid carcinoma. Otolaryngol Clin North Am 2005;38:161-78. (Pubitemid 40092935)
22. Haas SN. Management of papillary microcarcinoma of the thyroid. S D Med 2006;59:425-7.
23. Topliss D. Thyroid incidentaloma: the ignorant in pursuit of the impalpable. Clin Endocrinol (Oxf) 2004;60:18-20. (Pubitemid 38183492)
24. Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid micro- carcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;112:1139-46, discussion 46-7.
25. Loh KC, Greenspan FS, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab 1997; 82:3553-62. (Pubitemid 27509336)
26. Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998;82:375-88.
27. Bilimoria KY, Bentrem DJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375-81, discussion 81-4.
28. Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 2008;144:980-7, discussion 7-8.
29. Cobin RH, Gharib H, Bergman DA, et al. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001;7:202-20. (Pubitemid 32514878)
30. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-64, discussion 64-6.
31. Hay ID, Bergstralh EJ, Grant CS, et al. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery 1999;126:1173-81, discussion 81-2.
32. Beenken S, Roye D, Weiss H, et al. Extent of surgery for intermediate- risk well-differentiated thyroid cancer. Am J Surg 2000;179:51-6. (Pubitemid 30126010)
33. Byar DP, Green SB, Dor P, et al. A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 1979;15:1033-41.
34. Sugitani I, Kasai N, Fujimoto Y, et al. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135:139-48. (Pubitemid 38130764)
35. Hundahl SA, Fleming ID, Fremgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-48.
36. Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 1992;164:658-61.
37. Shaha AR, Loree TR, Shah JP. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 1994;116:1036-40, discussion 40-1.
38. Jukkola A, Bloigu R, Ebeling T, et al. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004;11:571-9. (Pubitemid 39331285)
39. Lang BH, Lo CY, Chan WF, et al. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging. Ann Surg Oncol 2007;14:730-8.
40. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002;26:879-85.
41. Schlumberger M. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306. (Pubitemid 28065257)
42. Cady B. Papillary carcinoma of the thyroid gland: treatment based on risk group definition. Surg Oncol Clin N Am 1998;7:633-44. (Pubitemid 28436532)
43. Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope 2004;114:393-402. (Pubitemid 38391898)
44. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419-25. (Pubitemid 28193527)
45. Yildirim E. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 2005;200:378-92. (Pubitemid 40298972)
46. Thompson LD, Wieneke JA, Paal E, et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer 2001;91:505-24.
47. Giddings AE. The history of thyroidectomy. J R Soc Med 1998;91 (Suppl 33):3-6.
48. Shindo ML, Sinha UK, Rice DH. Safety of thyroidectomy in residency: a review of 186 consecutive cases. Laryngoscope 1995;105:1173-5.
49. Herranz-Gonzalez J, Gavilan J, Matinez-Vidal J, et al. Complications following thyroid surgery. Arch Otolaryngol Head Neck Surg 1991; 117:516-8.
50. Tovi F, Noyek AM, Chapnik JS, et al. Safety of total thyroidectomy: review of 100 consecutive cases. Laryngoscope 1989;99:1233-7.
51. de Roy van Zuidewijn DB, Songun I, Kievit J, et al. Complications of thyroid surgery. Ann Surg Oncol 1995;2:56-60.
52. Scanlon EF, Kellogg JE, Winchester DP, et al. The morbidity of total thyroidectomy. Arch Surg 1981;116:568-71.
53. Prim MP, de Diego JI, Hardisson D, et al. Factors related to nerve injury and hypocalcemia in thyroid gland surgery. Otolaryngol Head Neck Surg 2001;124:111-4.
54. Steinmuller T, Klupp J, Wenking S, et al. Complications associated with different surgical approaches to differentiated thyroid carcinoma. Langenbecks Arch Surg 1999;384:50-3.
55. Wingert DJ, Friesen SR, Iliopoulos JI, et al. Post-thyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg 1986;152:606-10.
56. Bergamaschi R, Becouarn G, Ronceray J, et al. Morbidity of thyroid surgery. Am J Surg 1998;176:71-5.
57. Bhattacharyya N, Fried MP. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 2002;128:389-92.
58. Moulton-Barrett R, Crumley R, Jalilie S, et al. Complications of thyroid surgery. Int Surg1997;82:63-6.
59. Shaha A, Jaffe BM. Complications of thyroid surgery performed by residents. Surgery 1988;104:1109-14.